Assignment of Assignor's Interest

Recorded: 2021-11-18 Pages: 7

Assignors

BETTENCOURT, BRIAN

Executed: 2018-01-31

FITZGERALD, KEVIN

Executed: 2018-01-31

QUERBES, WILLIAM

Executed: 2018-01-31

Assignee

ALNYLAM PHARMACEUTICALS, INC.

300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142

Covered Property (1)

Compositions and Methods for Inhibiting Expression of the ALAS1 Gene

Application: 17/307,846 →

Publication: US 2023/0026968

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.